Overexpression of the Runx3 transcription factor increases the proportion of mature thymocytes of the CD8 single-positive lineage

Journal of Immunology

Volumn 174, Issue 5, 2005, Pages 2627-2636

  Kohu, Kazuyoshi ^a   Sato, Takehito ^b   Ohno, Shin Ichiro ^b   Hayashi, Keitaro ^a   Uchino, Ryuji ^a   Abe, Natsuma ^a   Nakazato, Megumi ^a   Yoshida, Naomi ^a   Kikuchi, Toshiaki ^a   Iwakura, Yoichiro ^c   Inoue, Yoshihiro ^a   Watanabe, Toshio ^a   Habu, Sonoko ^b   Satake, Masanobu ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR RUNX3;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CELL MATURATION; GENE OVEREXPRESSION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; SPLEEN CELL; T LYMPHOCYTE; THYMOCYTE; TRANSGENIC MOUSE;

EID: 20044383185     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.5.2627     Document Type: Article

References (33)

1. Anderson, G., B. C. Harman, K. J. Hare, and E. J. Jenkinson. 2000. Microenvironmental regulation of T cell development in the thymus. Semin. Immunol. 12:457.
2. Varas, A., A. L. Hager-Theodorides, R. Sacedon, A. Vicente, A. G. Zapata, and T. Crompton. 2003. The role of morphogens in T-cell development. Trends Immunol. 24:197.
3. Basson, M. A., and R. Zamoyska. 2000. The CD4/CD8 lineage decision: integration of signalling pathways. Immunol. Today 21:509.
4. Germain, R. N. 2002. T-cell development and the CD4-CD8 lineage decision. Nat. Rev. Immunol. 2:309.
5. Alberola-Ila, J., and G. Hernandez-Hoyos. 2003. The Ras/MAPK cascade and the control of positive selection. Immunol. Rev. 191:79.
6. Rothenberg, E. V. 2002. T-lineage specification and commitment: a gene regulation perspective. Semin. Immunol. 14:431.
7. Singer, A. 2002. New perspectives on a developmental dilemma: the kinetic signaling model and the importance of signal duration for the CD4/CD8 lineage decision. Curr. Opin. Immunol. 14:207.
8. Hayashi, K., W. Natsume, T. Watanabe, N. Abe, N. Iwai, H. Okada, Y. Ito, M. Asano, Y. Iwakura, S. Habu, et al. 2000. Diminution of the AML1 transcription factor function causes differential effects on the fates of CD4 and CD8 single-positive T cells. J. Immunol. 165:6816.
9. Hayashi, K., N. Abe, T. Watanabe, M. Obinata, M. Ito, T. Sato, S. Habu, and M. Satake. 2001. Overexpression of AML1 transcription factor drives thymocytes into the CD8 single-positive lineage. J. Immunol. 167:4957.
10. + thymocytes. J. Immunol. 171:3594.
11. Sato, T., R. Ito, S. Nunomura, S. Ohno, K. Hayashi, M. Satake, and S. Habu. 2003. Requirement of transcription factor AML1 in proliferation of developing thymocytes. Immunol. Lett. 89:39.
12. Ichikawa, M., T. Asai, T. Saito, G. Yamamoto, S. Seo, I. Yamazaki, T. Yamagata, K. Mitani, S. Chiba, H. Hirai, et al. 2004. AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis. Nat. Med. 10:229.
13. Taniuchi, I., M. Osato, T. Egawa, M. J. Sunshine, S. C. Bae, T. Komori, Y. Ito, and D. R. Littman. 2002. Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development. Cell 111:621.
14. Woolf, E., C. Xiao, O. Fainaru, J. Lotem, D. Rosen, V. Negreanu, Y. Bernstein, D. Goldenberg, O. Brenner, G. Berke, et al. 2003. Runx3 and Runx1 are required for CD8 T cell development during thymopoiesis. Proc. Natl. Acad. Sci. USA 100:7731.
15. Levanon, D., V. Negreanu, Y. Bernstein, I. Bar-Am, L. Avivi, and Y. Groner. 1994. AML1, AML2, and AML3, the human members of the runt domain gene-family: cDNA structure, expression, and chromosomal localization. Genomics 23:425.
16. Garvin, A. M., K. M. Abraham, K. A. Forbush, A. G. Farr, B. L. Davison, and R. M. Perlmutter. 1990. Disruption of thymocyte development and lymphomagenesis induced by SV40 T-antigen. Int. Immunol. 2:173.
17. Sato, T., T. Sasahara, Y. Nakamura, T. Osaki, T. Hasegawa, T. Tadakuma, Y. Arata, Y. Kumagai, M. Katsuki, and S. Habu. 1994. Naive Tcells can mediate delayed-type hypersensitivity response in T cell receptor transgenic mice. Eur. J. Immunol. 24:1512.
18. Chiba, N., T. Watanabe, S. Nomura, Y. Tanaka, M. Minowa, M. Niki, R. Kanamaru, and M. Satake. 1997. Differentiation dependent expression and distinct subcellular localization of the protooncogene product, PEBP2β/CBFβ, in muscle development. Oncogene 14:2543.
19. Kanto, S., N. Chiba, Y. Tanaka, S. Fujita, M. Endo, N. Kamada, K. Yoshikawa, A. Fukuzaki, S. Orikasa, T. Watanabe, and M. Satake. 2000. The PEBP2β/CBFβ-SMMHC chimeric protein is localized both in the cell membrane and nuclear subtractions of leukemic cells carrying chromosomal inversion 16. Leukemia 14:1253.
20. Tanaka, Y., T. Watanabe, N. Chiba, M. Niki, Y. Kuroiwa, T. Nishihira, S. Satomi, Y. Ito, and M. Satake. 1997. The protooncogene product, PEBP2β/CBFβ, is mainly located in the cytoplasm and has an affinity with cytoskeletal structures. Oncogene 15:677.
21. Liu, X., and R. Bosselut. 2004. Duration of TCR signaling controls CD4-CD8 lineage differentiation in vivo. Nat. Immunol. 5:280.
22. + T-cell lineage fate. Nature 404:506.
23. Hogquist, K. A. 2001. Signal strength in thymic selection and lineage commitment. Curr. Opin. Immunol. 13:225.
24. Zou, Y. R., M. J. Sunshine, I. Taniuchi, F. Hatam, N. Killeen, and D. R. Littman. 2001. Epigenetic silencing of CD4 in T cells committed to the cytotoxic lineage. Nat. Genet. 29:332.
25. + cells but markedly decreased helper cell activity in mice lacking CD4. Nature 353:180.
26. Sawada, S., J. D. Scarborough, N. Killeen, and D. R. Littman. 1994. A lineage-specific transcriptional silencer regulates CD4 gene expression during T lymphocyte development. Cell 77:917.
27. Telfer, J. C., E. E. Hedblom, M. K. Anderson, M. N. Laurent, and E. V. Rothenberg. 2004. Localization of the domains in Runx transcription factors required for the repression of CD4 in thymocytes. J. Immunol. 172:4359.
28. Nawijn, M. C., R. Ferreira, G. M. Dingjan, O. Kahre, D. Drabek, A. Karis, F. Grosveld, and R. W. Hendriks. 2001. Enforced expression of GATA-3 during T cell development inhibits maturation of CD8 single-positive cells and induces thymic lymphoma in transgenic mice. J. Immunol. 167:715.
29. Hernandez-Hoyos, G., M. K. Anderson, C. Wang, E. V. Rothenberg, and J. Alberola-Ila. 2003. GATA-3 expression is controlled by TCR signals and regulates CD4/CD8 differentiation. Immunity 19:83.
30. Pai, S. Y., M. L. Truitt, C. N. Ting, J. M. Leiden, L. H. Glimcher, and I. C. Ho. 2003. Critical roles for transcription factor GATA-3 in thymocyte development. Immunity 19:863.
31. Wilkinson, B., J. Y. Chen, P. Han, K. M. Rufner, O. D. Goularte, and J. Kaye. 2002. TOX: an HMG box protein implicated in the regulation of thymocyte selection. Nat. Immunol. 3:272.
32. Aliahmad, P., E. O'Flaherty, P. Han, O. D. Goularte, B. Wilkinson, M. Satake, J. D. Molkentin, and J. Kaye. 2004. TOX provides a link between calcineurin activation and CD8 lineage commitment. J. Exp. Med. 199:1089.
33. Robey, E., D. Chang, A. Itano, D. Cado, H. Alexander, D. Lans, G. Weinmaster, and P. Salmon. 1996. An activated form of Notch influences the choice between CD4 and CD8 T cell lineages. Cell 87:483.